Gain Access to exclusive preclinical content.
Complete the form below to gain access to mattis aliquet nunc aliquam tempor. We’ll assign a user name and password, then send you a link. Thanks!

Get Access Register

EXCLUSIVE PRECLINICAL CONTENT.
You must log in to access content on this page. Or click here to request access.
Glycogen synthase kinases 3-α/β inhibition attenuates progression of diabetic kidney disease beyond treatment with metformin/Ramipril/empagliflozin

Lidia Anguiano Gómez Manga Motrapu Julian Marschner Hans-Joachim Anders, “NGlycogen synthase kinases 3-α/β inhibition attenuates progression of diabetic kidney disease beyond treatment with metformin/Ramipril/empagliflozin,” Nephrology Dialysis Transplantation, Volume 34, Issue Supplement_1, June 2019, gfz096.FO051, https://doi.org/10.1093/ndt/gfz096.FO051.